文献速递呼吸危重症与机械通气

经鼻高流量氧疗对成人急性呼吸衰竭气管插管率的系统评价与荟萃分析

Can High-flow Nasal Cannula Reduce the Rate of Endotracheal Intubation in Adult Patients With Acute Respiratory Failure Compared With Conventional Oxygen Therapy and Noninvasive Positive Pressure Ventilation?: A Systematic Review and Meta-analysis.
PubMed 文献 · Chest · 2017-01-13

结果显示,与COT相比,HFNC与较低的气管插管率相关(z=2.55,P=.01);与NIPPV相比,气管插管率无显著差异(z=1.40,P=.16)。HFNC在ICU死亡率及ICU住院时间方面未显示优于COT或NIPPV。

要点

  • 与常规氧疗相比,HFNC可降低成人急性呼吸衰竭患者的气管插管率。
  • 与无创正压通气相比,HFNC在气管插管率上无显著差异。
  • HFNC在ICU死亡率和ICU住院时间上未优于COT或NIPPV。

核心结论

  • 在成人急性呼吸衰竭患者中,HFNC在降低气管插管率方面优于常规氧疗,但与无创正压通气相比无显著差异。

研究设计与样本

  • 系统评价与荟萃分析,检索PubMed、Embase、Medline、Cochrane Central Register of Controlled Trials及Web of Science数据库,纳入比较HFNC与NIPPV及COT的对照研究。

主要发现

  • 与COT相比,HFNC与较低的气管插管率相关(z=2.55,P=.01)。
  • 与NIPPV相比,HFNC在气管插管率上无显著差异(z=1.40,P=.16)。
  • HFNC在ICU死亡率及ICU住院时间方面未显示优于COT或NIPPV。
  • HFNC与NIPPV比较中,ICU死亡率(I2=67%,χ2=12.21,P=.02)和气管插管率(I2=63%,χ2=13.51,P=.02)存在显著异质性,其余结局指标未发现显著异质性。

临床怎么用

  • 对于成人急性呼吸衰竭患者,HFNC可作为替代常规氧疗的选择以降低气管插管风险。
  • HFNC与NIPPV在气管插管率上效果相当,选择时需结合患者具体情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The effects of high-flow nasal cannula (HFNC) on adult patients with acute respiratory failure (ARF) are controversial. We aimed to further determine the effectiveness of HFNC in reducing the rate of endotracheal intubation in adult patients with ARF by comparison to noninvasive positive pressure ventilation (NIPPV) and conventional oxygen therapy (COT). METHODS: The PubMed, Embase, Medline, and the Cochrane Central Register of Controlled Trials databases, as well as the Information Sciences Institute Web of Science, were searched for all controlled studies that compared HFNC with NIPPV and COT in adult patients with ARF. The primary outcome was the rate of endotracheal intubation; the secondary outcomes were ICU mortality and length of ICU stay. RESULTS: Eighteen trials with a total of 3,881 patients were pooled in our final studies. Except for ICU mortality (I2 = 67%, χ2 = 12.21, P = .02) and rate of endotracheal intubation (I2 = 63%, χ2 = 13.51, P = .02) between HFNC and NIPPV, no significant heterogeneity was found in outcome measures. Compared with COT, HFNC was associated with a lower rate of endotracheal intubation (z = 2.55, P = .01) while no significant difference was found in the comparison with NIPPV (z = 1.40, P = .16). As for ICU mortality and length of ICU stay, HFNC did not exhibit any advantage over either COT or NIPPV. CONCLUSIONS: In patients with ARF, HFNC is a more reliable alternative than NIPPV to reduce the rate of endotracheal intubation than COT.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Ni YN, Luo J, Yu H, et al. Can High-flow Nasal Cannula Reduce the Rate of Endotracheal Intubation in Adult Patients With Acute Respiratory Failure Compared With Conventional Oxygen Therapy and Noninvasive Positive Pressure Ventilation?: A Systematic Review and Meta-analysis. Chest. 2017. PMID: 28089816. doi:10.1016/j.chest.2017.01.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。